| Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility L Kalich-Philosoph, H Roness, A Carmely, M Fishel-Bartal, H Ligumsky, ... Science translational medicine 5 (185), 185ra62-185ra62, 2013 | 509 | 2013 |
| Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer I Wolf, S Levanon-Cohen, S Bose, H Ligumsky, B Sredni, H Kanety, ... Oncogene 27 (56), 7094-7105, 2008 | 375 | 2008 |
| Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). R Bakimer, P Fishman, M Blank, B Sredni, M Djaldetti, Y Shoenfeld The Journal of clinical investigation 89 (5), 1558-1563, 1992 | 346 | 1992 |
| A new immunomodulating compound (AS-101) with potential therapeutic application B Sredni, RR Caspi, A Klein, Y Kalechman, Y Danziger, M Benya'Akov, ... Nature 330 (6144), 173-176, 1987 | 219 | 1987 |
| Alloreactivity of an antigen-specific T-cell clone B Sredni, RH Schwartz Nature 287 (5785), 855-857, 1980 | 195 | 1980 |
| Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. P Fishman, E Falach-Vaknine, R Zigelman, R Bakimer, B Sredni, ... The Journal of clinical investigation 91 (4), 1834-1837, 1993 | 176 | 1993 |
| The protective role of the immunomodulator AS101 against chemotherapy‐induced alopecia studies on human and animal models B Sredni, RH Xu, M Albeck, U Gafter, R Gal, A Shani, T Tichler, J Shapira, ... International journal of cancer 65 (1), 97-103, 1996 | 167 | 1996 |
| Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention Y Kalechman, U Gafter, R Gal, G Rushkin, D Yan, M Albeck, B Sredni The Journal of Immunology 169 (1), 384-392, 2002 | 157 | 2002 |
| REM sleep deprivation in rats results in inflammation and interleukin-17 elevation S Yehuda, B Sredni, RL Carasso, D Kenigsbuch-Sredni Journal of Interferon and Cytokine Research 29 (7), 393-398, 2009 | 153 | 2009 |
| Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop B Sredni, M Weil, G Khomenok, I Lebenthal, S Teitz, Y Mardor, Z Ram, ... Cancer research 64 (5), 1843-1852, 2004 | 145 | 2004 |
| Direct cloning and extended culture of antigen-specific MHC-restricted, proliferating T lymphocytes B Sredni, HY Tse, RH Schwartz Nature 283 (5747), 581-583, 1980 | 143 | 1980 |
| Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage M Huberman, F Shalit, I Roth-Deri, B Gutman, C Brodie, E Kott, B Sredni Journal of neuroimmunology 52 (2), 147-152, 1994 | 142 | 1994 |
| Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS 101 B Sredni, T Tichler, A Shani, R Catane, B Kaufman, G Strassmann, ... JNCI: Journal of the National Cancer Institute 88 (18), 1276-1284, 1996 | 134 | 1996 |
| Tellurium compounds: selective inhibition of cysteine proteases and model reaction with thiols A Albeck, H Weitman, B Sredni, M Albeck Inorganic Chemistry 37 (8), 1704-1712, 1998 | 127 | 1998 |
| Immunomodulating tellurium compounds as anti-cancer agents B Sredni Seminars in cancer biology 22 (1), 60-69, 2012 | 119 | 2012 |
| Ultrastructural, biochemical, and functional characteristics of histamine-containing cells cloned from mouse bone marrow: tentative identification as mucosal mast cells. B Sredni, MM Friedman, CE Bland, DD Metcalfe Journal of immunology (Baltimore, Md.: 1950) 131 (2), 915-922, 1983 | 116 | 1983 |
| Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen. B Sredni, D Volkman, RH Schwartz, AS Fauci Proceedings of the National Academy of Sciences 78 (3), 1858-1862, 1981 | 116 | 1981 |
| T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease F Shalit, B Sredni, C Brodie, E Kott, M Huberman Clinical immunology and immunopathology 75 (3), 246-250, 1995 | 110 | 1995 |
| Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. B Sredni, M Albeck, T Tichler, A Shani, J Shapira, I Bruderman, R Catane, ... Journal of Clinical Oncology 13 (9), 2342-2353, 1995 | 105 | 1995 |
| Antigen‐Specific, Proliferating T Lymphocyte Clones. Methodology, Specificity, MHC Restriction and Alloreactivity B Sredni, RH Schwartz Immunological Reviews 54 (1), 187-223, 1981 | 101 | 1981 |
